Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on ZY-A001 Obtaining Notice of Approval for Drug Clinical Trials

· Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on ZY-A001 Obtaining Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment